Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06205589
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-01-04
Brief Title:
Therapeutic ID93 GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
Sponsor:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Organization:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-04
First Submit QC Date:
January 4 2024
Study First Post Date:
2024-01-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-02
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL